PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis

Published:2007-01 Issue:1-2 Volume:182 Page:124-134
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Carter Laura L.,Leach Michael W.,Azoitei Mihai L.,Cui Junqing,Pelker Jeffrey W.,Jussif Jason,Benoit Steve,Ireland Gretchen,Luxenberg Deborah,Askew G. Roger,Milarski Kim L.,Groves Christopher,Brown Tom,Carito Brenda A.,Percival Karen,Carreno Beatriz M.,Collins Mary,Marusic Suzana

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference53 articles.

1. Immunotherapeutic approaches in multiple sclerosis;Adorini;J. Neurol. Sci.,2004

2. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes;Agata;Int. Immunol.,1996

3. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice;Ansari;J. Exp. Med.,2003

4. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system;Becher;J. Exp. Med.,2001

5. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses;Bennett;J. Immunol.,2003

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD‐1 regulation of pathogenic IL‐17‐secreting γδ T cells in experimental autoimmune encephalomyelitis;European Journal of Immunology;2024-07-12

2. An observational study investigating soluble immune checkpoints as indicators of severe COVID-19;Microbiology Spectrum;2024-07-02

3. Regulatory role of PI16 in autoimmune arthritis and intestinal inflammation: implications for Treg cell differentiation and function;Journal of Translational Medicine;2024-04-02

4. Association of plasma sPD‐1 and sPD‐L1 with disease status and future relapse in AQP4‐IgG (+) NMOSD;Annals of Clinical and Translational Neurology;2023-12-08

5. Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice;Cell Communication and Signaling;2023-11-09